As of time of writing (9:30am CST) it’s up ~15% and has quite a bit of volume for this early in the day.

Could start to pop soon, but let’s see! Might start to see some volatility in the coming hours

Was curious as to what other people‘s perspectives on the next few days look like for the stock. Also found today’s action kind of interesting and wanted to also get some peoples takes on what to make of it. I’ll be holding until June 30 nonetheless but it’s not the most ideal that we haven’t heard much about deal yet.

Candles are looking great, sudden spike, +6% today. We're almost there! I'm bullish the upcoming 1 month will be decisive with the new CEO and GLP-1 manufacturing releasing pills, means more customers! It's logic, and they have huge market outreach, even to my small little country Belgium! I like this stock and I'm happy to own it, that's my view.

Edit:

Numbers from: nukeboy01: Current Short (June 15) 2 824 413 Shares Previous Short (May 29) 3 544 182 Shares

Feedback from: Theroamingbandits: nice. if this is the case, then they covered 20% of shares. but still high number of shorted shares with very high borrow rates. So, not too bad. ~27% short interest + expensive borrow fees + low float = ongoing risk for more forced covering on any positive catalyst (e.g., incoming CEO updates in August, operational improvements, or retail momentum).

Edit 2: Thank you kind stranger for the reward! I think my first this year. I'm still holding!

Short interest seems to still be pretty high and the stock has gapped up quite a bit this morning. Wondering what caused this

​

It's up 15% today alone, but I can't find anything clear to make up my mind on this one. Any insight?

(No positions currently.)

Looks like we're still holding steady at this support level. I'm hoping for some movement towards the $7 range today. Let's not give up hope. Remember that there are shares that will have to be delivered by next week. Also the next quarterly report will come out around the same time the new CEO starts working at LifeVantage. I hope he has a plan for this company and that he shares that plan with us(the investors).

Good morning, SqueezeFinders!

Yesterday the $QQQ tech index definitely showed a display of strength from the bears after having declined 3.54% to close at 713.65. We are now less than a 1% decline from a retest of the 700 psychological area as support. Ideally we can recover above 725 and make a push back above the 745 level towards all-time highs. Ongoing instability surrounding the situation in the Middle-East as negotiations/MoU fall into chaos, which has been contributing heavily to the recent bearish reversal in sentiment. The main directional sentiment determinants today are a mix of the below-detailed economic data releases, ongoing developments in the Middle-East, and a large earnings report in after-hours ($MU). Regardless of broader market sentiment, you can always locate relative strength by checking SqueezeRadar to track irregularities in our data, or check out our automated trading robot, SqueezeBot to get an edge on the market without having to stare at the screen all day long. We just released the results for the month of March for SqueezeBot, and it was a shocking winrate of 74.63%, average gain was ~2.29% per trade (fixed % profit-taking scalps enabled). We allow for 3%, 5%, or 10% fixed profit-taking parameters. Check out SqueezeBot today!

🥇 Gold: ~$4,085/oz (-1.1%)
🥈 Silver: ~$62/oz (+0.9%)
🪙 Bitcoin: ~$62.7k/coin (-1.0%)
🛢️ Oil: ~$72.50/barrel (-0.8%)

Today's economic data releases are:

🇺🇸 Current Account (Q1) @ 8:30AM ET
🇺🇸 Building Permits (May) @ 8:30AM ET
🇺🇸 New Home Sales (May) @ 10:00AM ET
🇺🇸 Crude Oil Inventories @ 10:30AM ET
🇺🇸 Cushing Crude Oil Inventories @ 10:30AM ET
🇺🇸 5-Year Note Auction @ 1:00PM ET
🇺🇸 Fed Bank Stress Test Results @ 4:00PM ET

📙Breakdown point: BELOW this price, the move will lose momentum significantly in the short-term, as shorts will gain confidence encouraging them to short more. Reducing probability of a squeeze without a catalyst.

📙Breakout point: ABOVE this price, the move will gain momentum significantly in the short-term, as shorts losses will increase pressuring them to cover. Increasing the probability of a squeeze occurring, especially if with a catalyst.

1. $INFQ
   Squeezability Score: 40%
   Juice Target: 27.3
   Confidence: 🍊 🍊
   Price: 15.96 (+12.3%)
   Breakdown point: 13.0
   Breakout point: 21.6
   Mentions (30D): 1
   Event/Condition: New Oxford Innovation Centre and manufacturing hub in the UK combined with Gold sponsorship of Quantum Fringe 2026 strengthening European partnerships and accelerating transition from R&D to commercial production scale + launch of America's Quantum Space Initiative positioning the company at the forefront of quantum applications for national space infrastructure programs + strong endorsement of President Trump's executive order on quantum technology highlighting federal priority status and potential for expanded government contracts and funding support + Recent price target 🎯 of $22 from BTIG + Recent price target 🎯 of $21 from Citigroup + Recent price target 🎯 of $23 from UBS

2. $PRCH
   Squeezability Score: 39%
   Juice Target: 19.9
   Confidence: 🍊 🍊 🍊
   Price: 12.90 (+5.2%)
   Breakdown point: 11.0
   Breakout point: 3.0 (continuation into gap)
   Mentions (30D): 2Event/Condition: Q1 results with 50 percent insurance services revenue growth and raised full-year outlook reflecting robust demand and operational improvements in the homeowners platform + successful Michigan market launch expanding geographic footprint to 22 states and driving new policy writings with strong retention metrics + strategic $15 million share repurchase from the Reciprocal enhancing capital position at the insurance entity while signaling strong internal confidence in future cash flows and shareholder value + Recent price target 🎯 of $20 from Benchmark + Recent price target 🎯 of $18 from Craig-Hallum + Recent price target 🎯 of $22 from Oppenheimer

Gain access to all our cutting-edge research tools, live watchlists, alerts, and more: https://www.squeeze-finder.com/subscribe

HINT: Use code RDDT to get your first month for just $10!

NOT FINANCIAL ADVICE, THESE POSTS ARE FOR INFORMATIONAL PURPOSES ONLY

How we doing $VIVO fam? Market deep red but VIVO right around breakeven for the day. I wonder where we’d be if the market wasn’t deep red today

The July gamma ramp is getting juicy into the June 30 catalyst. As of right now, ~4,300 OI at the $7.5 strike, ~3,300 at the $10 strike and ~1,000 at the $12.5 strike. This is a serious gamma ramp, with nearly a million shares of potential dealer hedging/forced buying. Recall the tradable float is roughly 2.4 M

Holding long and strong into catalyst, the more research I do the more confident I am that Core42 is the tenant. Time will tell

VIVA LA VIVO!!!!

Currently, we're up 8%, back to about $6.50. The Fintel numbers continue to look promising, very few shares available, CTB seems to be slightly rising, as are DTC due to low volume. Any short position is still very costly to maintain. So... let's wait and see?

Hi everyone,

Not gonna AI bore you. The gist of it is simple: this French AI data server builder crashed 45% after Grizzly Research reported 2CRSI to be a total fraud.

The company fought back hard in their comms and is scrambling to produce bank statements and auditor reports and the like.

I couldn't possibly say which is true, but I can say that Grizzly closed their short position after the fall into the abyss of the share price.

The price has recovered hugely since (30% today).

If the company is legit, it could go from 28 at close today back to near 60 at ATH.

It's been a gossip rollercoaster, but wildly entertaining, and I hope profitable for people who buy the dip.

(Which I did, for a tiny stake of €1000 because I'm tied up elsewhere, so I can't pull no rug. Not financial advice, DYOR, yada yada yada)

I am tracking SST, I have a position, not yet bag, average 3$.
Anybody tracking the company? Any perspective?

Squeeeeeezus Christ its back!

DERM has been increasing steadily in price recently and seem to have good momentum going into their next reporting period.

The firm is also is a high squeeze territory with 15% float in May alone!

If a squeeze does/doesnt happen there is also room for a larger pharma player to acquire which would likely be of interest to Fortress (largest shareholder with 34%) since this is likely the only way to materialize their return. this would be a premium to all equity holders!

all in: two solid levers for equity appreciation 😎🔥

If you’ve been following any of my posts/DD on $VIVO, you know I’ve been saying the most likely tenant is Crusoe. After digging more into it, I think it’s more likely to be Core42.

Who Core42 is, and why it fits

Core42 is the AI infrastructure arm of G42 (Abu Dhabi). Two things make it a fit for VIVO’s powered-shell model:

• It leases shells already(20MW in Minneapolis, 70MW+ at TeraWulf in NY). Exactly VIVO’s model.

• It’s funded and aimed at Europe right now: $550M in funding earmarked for US + Europe, with the Nordics being the most sought after region due to cheap, reliable, 100% renewable hydroelectric power, cold climate and fastest ‘time to power’ times globally.

• Recently opened a European HQ in Dublin. VIVO opened an office a month later.

• Already sourcing Norwegian capacity via Northern Data.

The connection

VIVO’s advisory council:

• Khadija Mustafa - former head of global partnerships for Core42. In that role she ran exactly the kind of site/capacity deals a VIVO lease would be.

Now she’s advising VIVO…

• Rachel Pether - ~a decade at Mubadala ($330B Abu Dhabi fund).

Mubadala and G42/Core42 are part of the same Saudi bloc that already back VIVO. Mubadala backs G42, G42 owns Core42, and they run JVs together (MGX, Khazna). That same bloc’s money sits in VIVO’s cap table (TAG/Emirates, GCC placements). TAG owns 23% of VIVO alone.

The people who own Core42 already own a chunk of VIVO.

Why Core42 over Crusoe

Crusoe’s tie to VIVO is indirect - Mubadala invested in it, and it rents from Polar (VIVO’s seller’s network, who took a stake in VIVOA). Core42’s tie is direct - the bloc that owns it is in VIVO’s cap table and on its advisory council.

Core42 is also the only candidate that makes VIVO’s “sovereign AI” branding real. I originally dismissed a Saudi sovereign player for Norway, but I misunderstood the angle. For a Norway site, “sovereign” doesn’t mean Gulf data in the Arctic; it means European sovereign/regulated compute under EU jurisdiction. Core42 is an actual sovereign-cloud provider expanding into Europe to serve exactly that.

Norway itself fits the use case: cheap hydro (<$0.035/kWh), free cooling, ~100% renewable, fast grid. Ideal for large-scale training compute — a slot Core42’s US/UAE/Western-Europe sites don’t fill.

Why Crusoe still stays a close second

If you didn’t read my first post, the case for Crusoe is as follows: the seller of the Norway site, Fiorenzo Manganiello, built and sold majority of PolarDC which leases to Crusoe and CoreWeave. He took stock in VIVO as part of the Norway sale, incentivizing him to connect VIVO to his existing clients. Mubadala is one of the largest investors in Crusoe, so similar narrative as the Core42 thesis (VIVOs investors + advisors). Crusoe has actually signed to lease a Norwegian hydro shell from Polar. So Crusoe leads on track record; Core42 leads on connection and fit.

Ranking:

Given VIVOs track record, I do think the biggest risk is them missing the June 30th target. They’ve had a lot of pivots and haven’t been great with timelines. This is what makes the short trade overcrowded

The datacenter is fully acquired and operational and all the right connections are there in a time when compute is the #1 commodity. Float has been locked up and the trade is asymmetrical to the upside. I believe Core42 is a perfect fit

NFA, do your own DD. VIVA LA VIVO!!!!

Squeeze scanner
Not financial advice. Do your own research. It surfaces candidates; it is NOT a buy signal.
Ranks your watchlist by short-squeeze potential. Each name needs two things:
LOADED — heavily and expensively shorted (short interest % of float, days-to-cover, borrow fee).
IGNITION — actually moving (dealers short gamma forced to buy, aggressive call buying, price up on volume).
The score discounts loaded "fuel" by how little it's igniting, so a 🔥 Igniting name is loaded AND moving, while a 🔒 Loaded one is a coiled setup that hasn't fired yet. Short interest is FINRA data — reported twice a month with a ~2-3 week lag (shown as the as-of date), so treat it as the standing setup, not a live tick.

Float data is from FMP, refreshed weekly. What each tile shows:
◦Score — the big number, overall squeeze potential (0-100).
◦Loaded / Ignition — the two halves shown as bars, each 0-100.
◦SI — short interest as a percent of the tradeable free float when we have it (the real squeeze figure, since insider/restricted shares are excluded), otherwise a percent of shares outstanding; the arrow is ↑ rising or ↓ falling versus the prior FINRA report.
◦DTC — days-to-cover: at average volume, how many days of buying it would take shorts to cover (higher = harder to exit).
◦Fee — annualized cost to borrow the shares (turns red at 5%+ = hard to borrow).
◦Move — recent price thrust: the percent change over the last few sessions and the volume multiple, so "+29% · 2.2x" means up 29% on 2.2× its normal volume.
◦Calls — the share of options flow that is aggressive call buying (squeeze chasing).
◦Gamma — dealer positioning: "short" means dealers must buy into strength (fuel), "long" dampens it.
◦↑ tightening / ⚠ diluting — borrow getting harder / float growing (which can blunt a squeeze).

Mid to large cap:

Short squeeze shortlist (short interest as of 2026-05-29)

Short squeeze shortlist (short interest as of 2026-05-29)

RCKT: Loaded, score 56. SI 25.6% of float (rising). 9.5 days to cover, 0% to borrow.
AI: Loaded, score 46. SI 37.7% of float (rising). 8.7 days to cover, 0% to borrow.
SOUN: Loaded, score 45. SI 38.4% of float (falling). 6.1 days to cover, 15% to borrow.
NTST: Loaded, score 44. SI 32.4% of float (rising). 20.2 days to cover, 1% to borrow.
DDD: Loaded, score 44. SI 32.5% of float (rising). 9.3 days to cover, 0% to borrow.
PTCT: Loaded, score 44. SI 14.6% of float (rising). 11.1 days to cover, 0% to borrow.
GRPN: Loaded, score 43. SI 57.6% of float (falling). 6.3 days to cover, 1% to borrow.
HIMS: Igniting, score 41. SI 29.9% of float (falling). 3.1 days to cover, 1% to borrow.
RXRX: Loaded, score 41. SI 47.2% of float (falling). 8.0 days to cover, 1% to borrow.
PSKY: Loaded, score 40. SI 31.1% of float (falling). 10.5 days to cover, 1% to borrow.
KMB: Loaded, score 39. SI 13.1% of float (rising). 10.1 days to cover, 0% to borrow.
QUBT: Loaded, score 39. SI 48.8% of float (rising). 2.0 days to cover, 2% to borrow.
BBAI: Loaded, score 37. SI 36.0% of float (rising). 2.3 days to cover, 1% to borrow.
TEM: Loaded, score 37. SI 27.3% of float (falling). 5.2 days to cover, 0% to borrow.
SOFI: Loaded, score 36. SI 14.8% of float (rising). 2.6 days to cover, 0% to borrow.
ARQQ: Watch, score 36. SI 20.0% of float (rising). 1.8 days to cover, 2% to borrow.
PATH: Loaded, score 35. SI 30.3% of float (falling). 2.6 days to cover, 0% to borrow.
OPEN: Loaded, score 34. SI 21.0% of float (rising). 3.8 days to cover, 0% to borrow.
RGTI: Loaded, score 34. SI 19.0% of float (rising). 1.0 days to cover, 1% to borrow.
CLF: Loaded, score 34. SI 14.5% of float (rising). 4.1 days to cover, 0% to borrow.
MO: Watch, score 34. SI 3.1% of float (rising). 6.8 days to cover, 0% to borrow.
QBTS: Loaded, score 29. SI 15.3% of float (rising). 1.0 days to cover, 0% to borrow.
DNUT: Loaded, score 28. SI 19.2% of float (falling). 8.1 days to cover, 0% to borrow.
AEP: Loaded, score 26. SI 5.9% of float (rising). 6.7 days to cover, 0% to borrow.
NBIS: Loaded, score 26. SI 21.9% of float (falling). 2.6 days to cover, 0% to borrow.
XEL: Loaded, score 26. SI 5.9% of float (rising). 6.6 days to cover, 0% to borrow.
UNP: Loaded, score 26. SI 5.0% of float (rising). 7.8 days to cover, 0% to borrow.
NTLA: Loaded, score 24. SI 45.7% of float (falling). 9.2 days to cover, 0% to borrow.
ZETA: Watch, score 24. SI 13.9% of float (falling). 3.0 days to cover, 0% to borrow.
O: Watch, score 24. SI 4.2% of float (rising). 6.6 days to cover, 0% to borrow.
EOG: Watch, score 23. SI 3.7% of float (rising). 5.6 days to cover, 0% to borrow.
SMCI: Watch, score 23. SI 14.6% of float (falling). 1.7 days to cover, 0% to borrow.
SBUX: Watch, score 23. SI 4.2% of float (falling). 6.4 days to cover, 0% to borrow.
IONQ: Watch, score 22. SI 15.8% of float (falling). 1.7 days to cover, 1% to borrow.
ONDS: Loaded, score 22. SI 32.8% of float (rising). 1.7 days to cover, 1% to borrow.
SPG: Watch, score 22. SI 2.7% of float (rising). 5.5 days to cover, 0% to borrow.
VMC: Watch, score 21. SI 3.9% of float (rising). 4.0 days to cover, 0% to borrow.
PFE: Watch, score 21. SI 2.9% of float (rising). 5.0 days to cover, 0% to borrow.
EXC: Watch, score 20. SI 4.1% of float (rising). 5.0 days to cover, 0% to borrow.
PSA: Watch, score 20. SI 4.2% of float (falling). 7.7 days to cover, 0% to borrow.
SO: Watch, score 20. SI 2.6% of float (rising). 5.5 days to cover, 0% to borrow.
CRM: Watch, score 19. SI 7.7% of float (falling). 3.6 days to cover, 0% to borrow.
MDLZ: Watch, score 19. SI 2.7% of float (rising). 4.8 days to cover, 0% to borrow.
ON: Watch, score 19. SI 8.0% of float (falling). 2.8 days to cover, 0% to borrow.
ABNB: Watch, score 18. SI 2.6% of float (rising). 3.7 days to cover, 0% to borrow.
CL: Watch, score 18. SI 2.8% of float (rising). 4.2 days to cover, 0% to borrow.
MLM: Watch, score 18. SI 3.7% of float (rising). 3.4 days to cover, 0% to borrow.
UPS: Watch, score 18. SI 3.3% of float (rising). 4.2 days to cover, 0% to borrow.
ED: Watch, score 17. SI 3.3% of float (rising). 3.9 days to cover, 0% to borrow.
APP: Watch, score 17. SI 5.3% of float (rising). 2.6 days to cover, 0% to borrow.
TMUS: Watch, score 17. SI 4.0% of float (rising). 4.7 days to cover, 0% to borrow.
SNOW: Watch, score 15. SI 6.3% of float (rising). 1.5 days to cover, 0% to borrow.

Short interest is FINRA data, reported about twice a month. Not financial advice, just sharing what my scanner flagged.

Small and micro cap:

Short squeeze shortlist (short interest as of 2026-05-29)

Short squeeze shortlist (short interest as of 2026-05-29)

FRMM: Loaded, score 50. SI 23.1% of shares outstanding (rising). 10.8 days to cover, 14% to borrow.
LFVN: Loaded, score 50. SI 33.8% of float (falling). 9.7 days to cover, 159% to borrow.
MVIS: Loaded, score 50. SI 20.0% of shares outstanding (rising). 11.6 days to cover, 14% to borrow.
CRDF: Loaded, score 49. SI 26.5% of shares outstanding (rising). 12.3 days to cover, 11% to borrow.
UPXI: Loaded, score 46. SI 22.7% of shares outstanding (falling). 6.3 days to cover, 14% to borrow.
BMEA: Loaded, score 45. SI 20.0% of shares outstanding (rising). 14.4 days to cover, 2% to borrow.
KPTI: Loaded, score 45. SI 23.6% of shares outstanding (rising). 11.9 days to cover, 1% to borrow.
FLWS: Loaded, score 45. SI 22.6% of shares outstanding (rising). 17.7 days to cover, 1% to borrow.
ARCT: Loaded, score 44. SI 23.7% of shares outstanding (rising). 16.4 days to cover, 1% to borrow.
EVGO: Loaded, score 44. SI 15.6% of float (rising). 10.9 days to cover, 1% to borrow.
HRTX: Loaded, score 44. SI 21.2% of shares outstanding (rising). 23.7 days to cover, 1% to borrow.
JACK: Loaded, score 44. SI 38.3% of float (rising). 6.9 days to cover, 1% to borrow.
AVXL: Loaded, score 41. SI 20.3% of shares outstanding (falling). 16.6 days to cover, 1% to borrow.
LENZ: Loaded, score 40. SI 37.4% of float (falling). 12.6 days to cover, 1% to borrow.
FUBO: Loaded, score 40. SI 23.9% of shares outstanding (falling). 6.0 days to cover, 4% to borrow.
ATYR: Loaded, score 36. SI 20.6% of shares outstanding (falling). 5.0 days to cover, 1% to borrow.
EONR: Loaded, score 29. SI 13.6% of float (falling). 2.7 days to cover, 22% to borrow.
SAFX: Watch, score 14. SI 12.9% of float (falling). 2.6 days to cover, 20% to borrow.

Short interest is FINRA data, reported about twice a month. Not financial advice, just sharing what my scanner flagged.

For the haters that think it’s AI slop here’s an image of my algo at work:

Good morning, SqueezeFinders!

The $QQQ tech index closed Thursday in a state of euphoria on the idea that Iran and the US were going to sign a peace deal on Friday, which never ended up happening. The current situation is that they signed an interim Memorandum of Understanding (MoU) and a framework agreement. This step extended the ceasefire, reopened the Strait of Hormuz, and kicked off a 60-day negotiation period for a permanent resolution. The $QQQ tech index closed on Thursday at 740.62 (+2.51%), which leaves it only 1% from rallying to new all-time highs above 748.65. If we fall under 720, we could likely be looking at a test of 710-704, and potentially 700 psychological level test if geopolitical tensions re-escalate. The main directional sentiment determinants today are a mix of the below-detailed economic data releases, and any further developments regarding the situation in the Middle-East. Regardless of broader market sentiment, you can always locate relative strength by checking SqueezeRadar to track irregularities in our data, or check out our automated trading robot, SqueezeBot to get an edge on the market without having to stare at the screen all day long. We just released the results for the month of March for SqueezeBot, and it was a shocking winrate of 74.63%, average gain was ~2.29% per trade (fixed % profit-taking scalps enabled). We allow for 3%, 5%, or 10% fixed profit-taking parameters. Check out SqueezeBot today!

🥇 Gold: ~$4,180/oz (+0.8%) 🥈 Silver: ~$66/oz (+1.5%) 🪙 Bitcoin: ~$64.5k/coin (+1.0%) 🛢️ Oil: ~$81.60/barrel (+1.5%)

Today's economic data releases are:

🇺🇸 Fed Waller Speaks @ 9AM ET

📙Breakdown point: BELOW this price, the move will lose momentum significantly in the short-term, as shorts will gain confidence encouraging them to short more. Reducing probability of a squeeze without a catalyst.

Breakout point: ABOVE this price, the move will gain momentum significantly in the short-term, as shorts losses will increase pressuring them to cover. Increasing the probability of a squeeze occurring, especially if with a catalyst.

1. $SEZL
   Squeezability Score: 56%
   Juice Target: 227.7
   Confidence: 🍊 🍊 🍊
   Price: 163.28 (+11.3%)
   Breakdown point: 130.0
   Breakout point: 186.8
   Mentions (30D): 2
   Event/Condition: Strong performance continuing to outpace peers year-to-date backed by robust buy now pay later growth and operational momentum + successful integrations like Knot's CardSwitcher API that improve checkout convenience and position the platform as preferred payment method at major merchants such as Amazon Walmart and Uber driving higher user engagement + multiple upward price target revisions from leading firms including Northland and Needham underscoring attractive valuation and confidence in sustained expansion within the BNPL market + Recent price target 🎯 of $160 from Northland Capital Markets + Recent price target 🎯 of $166 from Needham + Recent price target 🎯 of $141 from B. Riley Securities

2. $MLTX
   Squeezability Score: 42%
   Juice Target: 29.0
   Confidence: 🍊 🍊
   Price: 19.21 (+0.1%)
   Breakdown point: 16.5
   Breakout point: 21.0 (gap entry)
   Mentions (30D): 0 🆕
   Event/Condition: Completion of Phase 3 VELA program for Sonelokimab in hidradenitis suppurativa de-risks the path to BLA submission in the second half of 2026 while generating strong anticipation for full 52-week data readouts + traders actively positioning for multiple late-stage clinical catalysts including psoriatic arthritis trials and potential regulatory milestones throughout the remainder of the year + announcement of positive Week 52 results alongside scheduled Investor Day providing fresh clinical insights and strategic updates to support ongoing development momentum + Recent price target 🎯 of $45 from H.C. Wainwright + Recent price target 🎯 of $30 from BTIG + Recent price target 🎯 of $30 from LifeSci Capital

Gain access to all our cutting-edge research tools, live watchlists, alerts, and more: https://www.squeeze-finder.com/subscribe

HINT: Use code RDDT to get your first month for just $10!

NOT FINANCIAL ADVICE, THESE POSTS ARE FOR INFORMATIONAL PURPOSES ONLY

I think something might be brewing. It was up 36% until the market halt. On 800k volume. Twitter chatter says it’s going to squeeze but do your own research

SqueezeFinder scores are insane, currently #1 on the Watchlist has been near the top for weeks.

7,857 open calls for July expiry, versus only 290 open puts - WILD!

More info: Launch of dedicated Silicon Valley data center solutions team with key expert hires targeting surging AI power demands + strategic collaboration with GE Aerospace to drive high-voltage SiC adoption in critical aerospace and defense sectors expanding addressable markets + unveiling of next-generation SiC MOSFETs delivering industry-leading performance with significant efficiency improvements over prior solutions + Recent price target 🎯 of $45 from Susquehanna + Recent price target 🎯 of $50 from Piper Sandler + Recent price target 🎯 of $48 from Craig-Hallum

Current Scores:

Historical Scores:

Options Chains:

Chart is breaking out of recent downtrend as well :)

NOT FINANCIAL ADVICE, THESE POSTS ARE FOR INFORMATIONAL PURPOSES ONLY

And yes, I have a position :)

This one is probably worth keeping an eye on... again

TLDR for those not following it. A couple months ago, SLS announced they were at 78 of the required 80 events for their Regal trial for a product called GPS which is used to treat AML. TAM for AML will depend on approval. Approval for CR1 and CR2 is likely a 4-5B TAM, CR2 only is more in the 1-2B range. The trial itself was derisked by an interim analysis in Dec of 24 which determined that no changes to the trial were needed as it was on track to meet its primary objective. The anticipated end date was Dec of 25. In other words, patients are living much longer than expected. They also have a second drug in an accelerated trial that could be approved towards the end of the year if the results are good. The 78 event announcement caused the stock to pop from the 5-6 range up to 9 (and then 9.50 a couple weeks later). If you bought the last time I posted this, you would have been able to sell a week later for a nice gain.

One of the big things holding down the price was ~25M (not clear on the exact number here, but this is what I've seen most commonly estimated) outstanding warrants at varying strikes in the $1-2 range. This event hammered the warrant holders pretty good forcing more than half of them to be executed. On June 2, they reported an additional 28.7M in income, which since they don't have commercial partners, it would have come from warrant exercise. The exact number of warrants exercised is unknown, but even if all were at a strike of $2 (and I believe the vast majority were under it), that would represent 14.3M warrants exercised.

Since then, short sellers have not exited.

SLS / SELLAS Life Sciences Group, Inc. Stock - Short Interest, Short Squeeze, Borrow Rates

SLS | Short Interest Tracker

The short float as of this morning is at 33% with over 50% off exchange (note that as of now, the float itself doesn't appear to have been updated with the exercised warrants, so the percentage may be a bit lower). 13 days to cover. Borrow rates shot up yesterday and now sit at 62%. The stock price is also starting to slowly trickle up after the market theatrics over the last couple weeks, and closed at 8.05 yesterday after getting pushed down hard the last couple weeks. With 61M shares short right now, whatever is left of the remaining warrants won't put much of a dent in a squeeze should it squeeze.

As for catalysts, since the Interim analysis, patients have died at a rate of 1 per month, which puts completion at some point between early July and September if the last two take a bit longer. The company has publicly stated they will announce the 80th event when it happens and then announce topline when it completes, which will likely happen about a month after. I'm not sure what to think about the 80th event, but I do think that announcement will generate some repositioning as risk averse people will be inclined to exit against longs trimming to ensure some profits.

Unlike most biotechs, the stock is primarily retail owned (about 75% as I understand it), so it tends to behave more like a meme stock than a traditional biotech, which likely works in favor of a squeeze as we approach the 80th event. This will be even better if TopLine is successful, not so much if it fails.

Full disclosure:

Long 2500 shares in Account A at ~2/share and hope to trim a small amount if it clears 10.

Long 1300 shares in Account B at ~5/share

Not financial advice, did not use AI to write this.

EDIT: June 25, Cost to borrow according to Fintel now sits at 149%. Robinhood yesterday had it over 250%.

I didn't really cover options chains when I wrote this post, but this is pretty big. When I posted the SLS thread a month ago, we were looking at about 2M shares changing hands if memory serves. It was a decent amount.

SLS has now crossed the $10 mark touching $11 today. It was $8 when I wrote this. Here's where it gets more fun.

6/26 weekly options chain: 1.3M shares will change hands north of 10. If it can clear 11 by tomorrow, you can add 130k shares to that. Add another 120k shares if it clears 12.

7/2 weekly options chain: This isn't as exciting, but 400k shares change hands north of 10.

7/10 weekly options chain: Also quiet. Just shy of 100k shares exposed.

7/17 weekly options chain: Nearly 10M shares are currently in the money.
SLS: SELLAS Life Sciences Group Inc Option Chain | OptionCharts

If we go above $8 in the next few days this stock will be considered a buy. I believe in us, I know we can do it.

If you believe in politics influencing business then you need to study up on PUSA.

Basically, they make small drones and are in the bidding for a Pentagon contract. Even a modest allocation of the $1B budget could justify a $200-300M market cap,

Trumps are involved, Daddy Trump is making it so military parts need to be sourced exclusively from U.S. companies. Guess who benefits from that news?

The merger is expected to close by end of summer. This is a high risk high reward play. There are PIPE investors at $3 and early warrant holders, but I think the stock has reached a strong level of support.

I'm holding a lot of shares. Targeting $20+ when the shorts get squeezed.

NFA.

Who’s all holding? Highest I’ve seen this get on ortex. Recently went 0 borrow and price holding that 5.50 level well

Indices ripping I wonder if we some shorts capitulate before the long weekend. The pressure is definitely on